Pricing Log in Create free account

Heron Therapeutics, Inc. (HRTX) vs RenovoRx, Inc. (RNXT)

Heron Therapeutics, Inc. and RenovoRx, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and RenovoRx, Inc. are of similar size ($53.7M and $53.2M). Heron Therapeutics, Inc. has the higher net margin (−22.5% vs −469.0%) and the lower return on invested capital (−6.35% vs 0.00%). Across the 16 metrics below, Heron Therapeutics, Inc. leads on 9 and RenovoRx, Inc. on 7.

Valuation

Metric HRTX RNXT Biotechnology median
P/E n/m n/m 10.60
P/S 0.37 19.79 9.40
P/B 9.42 5.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.03 17.77 9.02
Earnings yield (65.52%) (27.19%) (32.88%)
Free cash flow yield (21.90%) (22.25%) (23.13%)

Profitability

Metric HRTX RNXT Biotechnology median
Gross margin 70.07% 84.04% 68.51%
Operating margin (7.19%) (489.05%) 0.00%
Net margin (22.52%) (469.02%) 0.00%
Free cash flow margin (8.00%) (440.38%) 0.00%
Return on equity 318.21% (149.98%) (51.96%)
Return on assets (14.06%) (110.14%) (46.06%)
Return on invested capital (6.35%) 0.00% 0.00%

Growth

Metric HRTX RNXT Biotechnology median
Revenue growth (TTM) 0.99% — 6.76%
EPS growth (last fiscal year) (33.33%) 20.00% 29.88%
Revenue growth, 5-year CAGR 11.81% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRTX RNXT Biotechnology median
Debt to equity 20.65 0.00 0.00
Current ratio 2.49 5.65 4.97
Net debt to EBITDA (643.88) 0.56 1.01

Dividend

Metric HRTX RNXT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HRTX RNXT Biotechnology median
Market cap 53.16m 53.70m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack